Advances in Chitin and Chitosan Science
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 September 2020) | Viewed by 29234
Special Issue Editor
Interests: antiparasite chemotherapy; research of antileishmanial drugs; mechanisms of drug action; mechanisms of drug resistance; drug targeting
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Chitosan, as the N-deacetylated derivative of chitin, is a biological polymer that has found many applications these two last decades, but its development still suffers from limitations in obtaining a defined chemical structure of the polymer using traditional preparation methods. New methods have recently emerged for obtaining the desired degree of deacylation, expanding the possibilities for applications.
Since the first consideration of chitosan as a biomaterial in the 90s, an increasing interest in this polymer has disseminated through many biological domains and, particularly, in the field of anti-infective chemotherapy, followed by vaccines.
This Special Issue aims to provide a forum for the dissemination of the latest studies including, firstly, new strategies to obtain more defined chemical structures and, secondly, the various approaches using chitosan for drug and vaccine delivery in order to improve anti-infective chemotherapy and vaccine efficacy.
Prof. Philippe M. LoiseauGuest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chitosan
- biomaterials
- drug delivery systems
- nanocarriers
- anti-infective chemotherapy
- vaccines
- infectious diseases
- parasites
- fungi
- bacteria
- virus
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.